Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

On November 6, 2023, Sensei Biotherapeutics Confirmed That On October 25, 2023 It Received An Unsolicited Proposal From Newtyn Management To Acquire The Company At $1.00 Per Share In Cash

Author: Benzinga Newsdesk | November 06, 2023 07:16am

Posted In: SNSE